JOYCE CHAMPAGNE: Open Payments
NPI 1588005128 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 53 payments from 18 companies in 2025. Trend: 2023 $854 · 2024 $1,076 · 2025 $1,098
Food & beverage: $1,034Education: $65
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $135 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Calliditas Therapeutics US Inc. | 4 | $106 |
| Mallinckrodt Hospital Products Inc. | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| AKEBIA THERAPEUTICS INC | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Vifor Pharma, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $40 |
Products named: FARXIGA, TARPEYO, ACTHAR, JYNARQUE, Wegovy, Vafseo, Kerendia, Ozempic.
Industry payments across LA — which companies pay providers there.
